5 studies were found.

1.		Completed	ABX-EGF (a monoclonal antibody) Given to Patients with Prostate Cancer with or without Tumor in Other Parts of the Body Condition: Prostate Cancer
2.		No longer recruiting	ABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) Conditions: Carcinoma, Non-Small-Cell Lung Neoplasm; Neoplasm Metastasis; Lung Cancer
3.		Completed	A blinded study comparing the safety and efficacy of a fully human anti-IL8 monoclonal antibody (ABX-IL8) to placebo in patients with chronic bronchitis and COPD Conditions: Pulmonary Disease, Chronic Obstructive; Bronchitis, Chronic
4.		Completed	A Research Study in Patients with Renal Cancer to Determine the Safety and Effectiveness of a New Investigational Drug Called ABX-EGF Condition: Renal Cell Carcinoma
5.		Completed	Study comparing ABX-CBL (monoclonal antibody) versus Atgam in Patients with Steroid Resistant Acute Graft versus Host Disease Condition: Graft vs Host Disease